Philip D Adamson
Overview
Explore the profile of Philip D Adamson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
2399
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weir-McCall J, Wereski R, Chen J, Zheng J, Kwiecinski J, Adamson P, et al.
Eur J Prev Cardiol
. 2025 Mar;
PMID: 40038072
Aims: To investigate the relationship between socioeconomic status, plaque burden on coronary computed tomography angiography (CCTA), management and outcomes. Methods: In a post-hoc analysis of a multicentre randomised control trial,...
2.
Williams M, Wereski R, Tuck C, Adamson P, Shah A, van Beek E, et al.
Lancet
. 2025 Jan;
405(10475):329-337.
PMID: 39863372
Background: The Scottish Computed Tomography of the Heart (SCOT-HEART) trial demonstrated that management guided by coronary CT angiography (CCTA) improved the diagnosis, management, and outcome of patients with stable chest...
3.
Wang X, Leng S, Adamson P, Greer C, Huang W, Lee H, et al.
Eur Heart J Cardiovasc Imaging
. 2025 Jan;
PMID: 39823456
Aims: To identify differences in CT-derived perivascular (PVAT) and epicardial adipose tissue (EAT) characteristics that may indicate inflammatory status differences between post-treatment acute myocardial infarction (AMI) and stable coronary artery...
4.
Gebert Z, Kwiecinski J, Weir-McCall J, Adamson P, Mills N, Roditi G, et al.
J Cardiovasc Comput Tomogr
. 2025 Jan;
PMID: 39788814
Background: Diabetes mellitus is an established cardiovascular risk factor. We assessed the impact of diabetes mellitus on quantitative plaque and long-term outcomes in patients with and without diabetes mellitus in...
5.
Wang X, Sia C, Adamson P, Greer C, Huang W, Lee H, et al.
J Am Heart Assoc
. 2024 Oct;
13(21):e037258.
PMID: 39470055
Background: The comparison of coronary computed tomography angiography plaques and perivascular adipose tissue (PVAT) between patients with acute myocardial infarction (AMI) posttreatment and patients with stable coronary artery disease is...
6.
McDermott M, Meah M, Khaing P, Wang K, Ramsay J, Scott G, et al.
JACC Cardiovasc Imaging
. 2024 Jul;
17(9):1101-1112.
PMID: 39001735
Coronary artery disease continues to be the leading cause of death globally. Identifying patients who are at risk of coronary artery disease remains a public health priority. At present, the...
7.
Kwiecinski J, Wang K, Tzolos E, Moss A, Daghem M, Adamson P, et al.
Eur J Nucl Med Mol Imaging
. 2024 Jun;
51(13):3934-3943.
PMID: 38926161
Introduction: There are sex differences in the extent, severity, and outcomes of coronary artery disease. We aimed to assess the influence of sex on coronary atherosclerotic plaque activity measured using...
8.
Wang K, Balmforth C, Meah M, Daghem M, Moss A, Tzolos E, et al.
J Am Coll Cardiol
. 2024 May;
83(22):2135-2144.
PMID: 38811091
Background: Total coronary atherosclerotic plaque activity across the entire coronary arterial tree is associated with patient-level clinical outcomes. Objectives: We aimed to investigate whether vessel-level coronary atherosclerotic plaque activity is...
9.
Deep A, Chan C, Adamson P, Troughton R, Woodcock E
CASE (Phila)
. 2024 May;
8(4):303-307.
PMID: 38765627
No abstract available.
10.
Chew-Harris J, Frampton C, Greer C, Appleby S, Pickering J, Kuan W, et al.
Int J Cardiol
. 2024 Apr;
406:132071.
PMID: 38643805
Aims: The performance of circulating soluble urokinase plasminogen activator receptor (suPAR) for predicting the composite endpoint of subsequent heart failure (HF) hospitalisation and/or death at 1 year was assessed in...